Cargando…
The prognostic value of circulating tumor DNA in patients with melanoma: A systematic review and meta-analysis
BACKGROUND: Circulating tumor DNA (ctDNA) has been investigated as a potential prognostic biomarker to evaluate the therapeutic efficacy and disease progression in melanoma patients, yet results remain inconclusive. The purpose of this study was to illustrate the prognostic value of ctDNA in melanom...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985561/ https://www.ncbi.nlm.nih.gov/pubmed/33744725 http://dx.doi.org/10.1016/j.tranon.2021.101072 |